ArticleHepatology communications2018

Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohort.

Paul Kwo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.